Skip to Content Facebook Feature Image

NeuWire Medical Appoints Ramin Mousavi as Executive Chairman Following Stroke Journal Publication.

Business

NeuWire Medical Appoints Ramin Mousavi as Executive Chairman Following Stroke Journal Publication.
Business

Business

NeuWire Medical Appoints Ramin Mousavi as Executive Chairman Following Stroke Journal Publication.

2026-05-12 19:36 Last Updated At:19:41

DALLAS--(BUSINESS WIRE)--May 12, 2026--

NeuWire Medical, a medical device company advancing the development of a targeted plasticity therapy platform for individuals living with chronic ischemic stroke, today announced the appointment of Ramin Mousavi as Executive Chairman of the Board. His arrival marks an important step in the company’s next phase of growth as NeuWire Medical prepares to advance its clinical, regulatory, and financing strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512337901/en/

Ramin joins NeuWire Medical following his role as President, Chief Executive Officer, and board member of CathWorks, where he led the company through a strategic partnership, global co-promotion agreement, landmark clinical trial, and eventual acquisition by Medtronic.

NeuWire is developing a closed-loop neuromodulation therapy designed to improve functional recovery in stroke survivors living with chronic motor deficits. The company’s technology pairs vagus nerve stimulation with targeted rehabilitation exercises, using an ultra-miniaturized, wireless, battery-free implant and intelligent stimulation timing to support neuroplasticity during therapy.

“I am very excited to join NeuWire Medical at this important moment,” said Ramin Mousavi, Executive Chairman of NeuWire Medical. “The progress achieved by Rob Rennaker and the team over the past years is impressive, both scientifically and clinically. NeuWire Medical is addressing one of the largest unmet needs in rehabilitation, and I look forward to supporting the company as it steps into its next chapter.”

NeuWire Medical is led by Rob Rennaker, PhD, Co-Founder and CEO, who has been deeply involved in the research and development of the company’s technology for over a decade. His work, together with collaborators across the field, has helped establish the scientific and clinical foundation for NeuWire Medical’s closed-loop VNS approach in post-stroke recovery.

The announcement follows the publication in Stroke, the journal of the American Heart Association, of clinical results from the company’s pilot study. The double-blinded, randomized, sham-controlled study evaluated a miniaturized closed-loop VNS system in individuals with chronic ischemic stroke and residual upper limb deficits.

The published data reported a favourable safety and feasibility profile, and statistically significant improvements in upper limb motor function following active closed-loop VNS therapy. The authors concluded that the system merits evaluation in a larger study.

“These results are an important validation point for our company,” said Rob Rennaker, PhD, Co-Founder and CEO of NeuWire Medical. “Our goal is to help stroke survivors achieve greater recovery by combining rehabilitation with precisely timed neuromodulation at home and in the clinic. We are now focused on securing the financing required to execute the pivotal study required to bring this therapy closer to patients.”

Dr. Rennaker added: “We are thrilled to welcome Ramin as Executive Chairman at this time. With an exceptional history of turning vision into results, Ramin is the ideal Executive Chairman to guide our next chapter of growth and value creation for NeuWire Medical.”

NeuWire Medical is preparing to raise capital to support its FDA IDE pivotal clinical study, regulatory activities, manufacturing scale-up, and preparation for future commercialization.

About NeuWire Medical

NeuWire Medical is developing a next-generation closed-loop vagus nerve stimulation platform for post-stroke rehabilitation. The system uses a miniature, wireless implant that delivers stimulation during high-quality therapeutic movements. By pairing active rehabilitation with precisely timed neuromodulation, NeuWire aims to enhance targeted neuroplasticity and improve functional recovery for stroke survivors.

NeuWire Medical’s VNS implant system is an investigational device and has not been approved or cleared by the U.S. Food and Drug Administration. The device is limited by U.S. law to investigational use. No claims of safety or effectiveness are made or implied.

CEO NeuWire Medical

CEO NeuWire Medical

Executive Chairman NeuWire Medical

Executive Chairman NeuWire Medical

NeuWire Medical Appoints Ramin Mousavi as Executive Chairman as company advances toward FDA pivotal study for post-stroke rehabilitation.

NeuWire Medical Appoints Ramin Mousavi as Executive Chairman as company advances toward FDA pivotal study for post-stroke rehabilitation.

CHICAGO--(BUSINESS WIRE)--May 12, 2026--

Aprimo, the leader in digital asset management and content operations solutions, today announced its May 2026 release: Interconnected Content Operations. The release expands Aprimo’s agentic AI, DAM, and unified platform capabilities to help enterprise marketing teams automate content workflows, improve asset discovery, streamline reviews, and connect digital assets, work management, and marketing spend.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511399244/en/

As marketing organizations increase their investments in AI, teams are under growing pressure to prove ROI, accelerate execution, and maintain governance across every stage of the content lifecycle. AI is changing how content is created, enriched, discovered, reviewed, and activated. Yet many organizations still manage these activities across disconnected tools, workflows, and teams.

With Interconnected Content Operations, Aprimo brings AI-powered automation, digital assets, work management, reviews, and spend controls into a more unified operating model for enterprise marketing teams. The release is designed to help brands reduce manual handoffs, improve visibility, and move content from planning to activation with greater speed, control, and confidence.

“AI alone is not the solution. The real breakthrough comes from connecting it to how marketing work actually gets done,” said Prabhakar Gopalan, President and Chief Operating Officer at Aprimo. “Enterprises need intelligent, interconnected content operations that eliminate silos, accelerate execution, and maintain control at scale. That is exactly what Aprimo is delivering with this release.”

The May 2026 release expands Aprimo’s platform across three key areas:

Agentic Content Operations

Aprimo is extending agentic capabilities across DAM and Spend to help teams automate more of the manual work that slows content operations. New capabilities help teams use librarian agents to customize ingestion, enrich complex content, and automate invoice processing.

A new MCP Server capability allows approved Aprimo content to connect with external AI-powered workflows. This helps teams search and use DAM content from corporate AI tools, making Aprimo-managed assets more accessible within the AI environments where enterprise teams already work.

DAM Usability

Aprimo is improving everyday DAM experiences so users can upload, protect, search, and reuse content faster. The release introduces new search enhancements that help users find the right assets with less manual effort, including:

Additional DAM improvements include bulk version uploads, upload history updates, and video watermarking for controlled review and sharing.

Unified Platform Experiences

Aprimo is creating a more connected experience across DAM and Productivity, helping teams find, review, and manage content and work objects from a single platform experience.

The Unified Search Experience brings work management and DAM results into a single results experience, helping users find content and work objects from one place. The Unified Mark-up and Annotation Viewer creates a more consistent review experience across collaboration and formal review workflows. A new Administration Experience modernizes navigation with faster access to frequently used configurations, searchable modules, and right-panel page loading.

“This release is designed to make intelligent content operations real in the day-to-day work of enterprise marketing teams,” Gopalan added. “By connecting AI, DAM, Productivity and Spend, Aprimo helps teams reduce manual handoffs, improve visibility, and move content from planning to activation with greater speed and governance.”

Aprimo’s latest product developments underscore the company’s continued focus on helping enterprises manage content with intelligence, automation, and governance. While many solutions focus narrowly on asset storage or point-level AI functionality, Aprimo connects strategy, budgeting, work management, digital assets, reviews, metadata, and delivery across a single content operations platform.

Interconnected Content Operations will be available to Aprimo customers worldwide as part of the May 2026 release.

For more details, visit: https://www.aprimo.com/platform/innovations

About Aprimo

Aprimo's agentic content operations platform enables organizations to govern, automate, and scale content in an AI-powered enterprise. Recognized as a leading vendor for innovation in agentic Digital Asset Management, Aprimo delivers a future-proof approach to content strategy, asset management, collaboration, personalization, and delivery.

Aprimo Interconnected Content Operations - May 2026

Aprimo Interconnected Content Operations - May 2026

Aprimo New Innovations - May 2026

Aprimo New Innovations - May 2026

Recommended Articles